Canada's first generic semaglutide changes the calculus on one of the most debated coverage decisions in group benefits today
Health Canada warnings and clinician concerns over fake products, side effects. and over‑reliance put semaglutide under closer scrutiny for benefit plans
Canada makes history as the first G7 nation to approve generic, Health Canada says
Just 2.1% of claimants now drive more than one‑third of private drug‑plan costs
